cefiderocol and Blast-Injuries

cefiderocol has been researched along with Blast-Injuries* in 1 studies

Other Studies

1 other study(ies) available for cefiderocol and Blast-Injuries

Article	Year
Carbapenem-Resistant Enterobacterales Infection After Massive Blast Injury: Use of Cefiderocol Based Combination Therapy. Military medicine, 2021, 11-02, Volume: 186, Issue:11-12 A military soldier sustained a blast injury in Afghanistan, resulting in amputations and hemipelvectomy. He developed New Delhi metallo-beta-lactamase-producing E. coli bacteremia, soft-tissue infection, and sacral osteomyelitis. These organisms are being increasingly discovered in different communities around the world. He was successfully treated with tigecycline and cefiderocol. Cefiderocol is a novel siderophore-based cephalosporine developed to treat serious infections, including those caused by carbapenem-resistant Enterobacterales. Topics: Anti-Bacterial Agents; Blast Injuries; Carbapenems; Cefiderocol; Cephalosporins; Escherichia coli; Humans; Male; Microbial Sensitivity Tests	2021

Article

Year

Carbapenem-Resistant Enterobacterales Infection After Massive Blast Injury: Use of Cefiderocol Based Combination Therapy.

Military medicine, 2021, 11-02, Volume: 186, Issue:11-12

A military soldier sustained a blast injury in Afghanistan, resulting in amputations and hemipelvectomy. He developed New Delhi metallo-beta-lactamase-producing E. coli bacteremia, soft-tissue infection, and sacral osteomyelitis. These organisms are being increasingly discovered in different communities around the world. He was successfully treated with tigecycline and cefiderocol. Cefiderocol is a novel siderophore-based cephalosporine developed to treat serious infections, including those caused by carbapenem-resistant Enterobacterales.

Topics: Anti-Bacterial Agents; Blast Injuries; Carbapenems; Cefiderocol; Cephalosporins; Escherichia coli; Humans; Male; Microbial Sensitivity Tests

2021